Lack of CD45 expression has a strong prognostic value in patients with multiple myeloma receiving high-dose therapy

被引：0
|
作者：
Moreau, P
Robillard, N
Avet-Loiseau, H
Morineau, N
Pineau, D
Milpied, N
Mahé, B
Vigier, M
Rapp, MJ
Harousseau, JL
Bataille, R
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [41] High-dose therapy in multiple myeloma and primary amyloidosis: An overview
    Kyle, RA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 83
  • [42] CD45 Expression in Plasma Cell Myeloma: Comparison of Flow Cytometry and Immunohistochemistry and Relationship to Prognostic Factors
    Rathke, S. K.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    MODERN PATHOLOGY, 2011, 24 : 317A - 317A
  • [43] CD45 Expression in Plasma Cell Myeloma: Comparison of Flow Cytometry and Immunohistochemistry and Relationship to Prognostic Factors
    Rathke, S. K.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    LABORATORY INVESTIGATION, 2011, 91 : 317A - 317A
  • [44] Clinical and biological correlates of CD45 expression on bone marrow plasma cells from patients with multiple myeloma.
    Kumar, S
    Rajkumar, SV
    Kimlinger, T
    Greipp, PR
    Witzig, TE
    BLOOD, 2004, 104 (11) : 918A - 918A
  • [45] Transplantation for multiple myeloma:: who, when, how often?: High-dose therapy in multiple myeloma
    Bladé, J
    BLOOD, 2003, 102 (10) : 3469 - 3470
  • [46] Prognostic value of serum β2-microglobulin in patients with multiple myeloma receiving combined therapy with bortezomib
    Luchinin, A. S.
    Zagoskina, T. P.
    Kulikova, M. M.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2010, 55 (01): : 18 - 21
  • [47] OUTCOMES OF FRAIL PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY/AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
    Yohay, Stephanie
    Oloyede, Temitope
    Dhakal, Binod
    D'Souza, Anita
    Aijaz, Ayesha
    Mohan, Meera
    Narra, Ravi
    Pasquini, Marcelo
    Hamadani, Mehdi
    Freeman, Ciara Louise
    Akhtar, Othman Salim
    BONE MARROW TRANSPLANTATION, 2024, 59 : 517 - 517
  • [48] Palifermin reduces intestinal toxicity and length of hospitalisation in multiple myeloma patients receiving high-dose melphalan
    Milone, G.
    Murgano, P.
    Pinto, V.
    Coppoletta, S.
    Battiato, K.
    Di Marco, A.
    Strano, A.
    Marturano, E.
    Mauro, E.
    Leotta, S.
    Poidomani, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S187 - S187
  • [49] Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma
    Worel, N
    Greinix, H
    Ackermann, J
    Kaufmann, H
    Urbauer, E
    Höcker, P
    Gisslinger, H
    Lechner, K
    Kalhs, P
    Drach, J
    ANNALS OF HEMATOLOGY, 2001, 80 (06) : 345 - 348
  • [50] Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma
    Worel N.
    Greinix H.
    Ackermann J.
    Kaufmann H.
    Urbauer E.
    Höcker P.
    Gisslinger H.
    Lechner K.
    Kalhs P.
    Drach J.
    Annals of Hematology, 2001, 80 (6) : 345 - 348
12345